Association of Severe Acute Kidney Injury with Mortality and Healthcare Utilization Following Isolated Traumatic Brain Injury.


Journal

Neurocritical care
ISSN: 1556-0961
Titre abrégé: Neurocrit Care
Pays: United States
ID NLM: 101156086

Informations de publication

Date de publication:
10 2021
Historique:
received: 10 09 2020
accepted: 22 12 2020
pubmed: 15 1 2021
medline: 16 11 2021
entrez: 14 1 2021
Statut: ppublish

Résumé

Traumatic brain injury (TBI) is a leading cause of morbidity, mortality, and disability in the USA. While cardiopulmonary dysfunction can result in poor outcomes following severe TBI, the impact of acute kidney injury (AKI) is poorly understood. We examined the association of severe AKI with hospital mortality and healthcare utilization following isolate severe TBI. We conducted a retrospective cohort study using the National Trauma Data Bank from 2007 to 2014. We identified a cohort of adult patients with isolated severe TBI and described the incidence of severe AKI, corresponding to Acute Kidney Injury Network stage 3 disease or greater. We examined the association of severe AKI with the primary outcome of hospital mortality using multivariable logistic regression models. In secondary analyses, we examined the association of severe AKI with dialysis catheter placement, tracheostomy and gastrostomy utilization, and hospital length of stay. There were 37,851 patients who experienced isolated severe TBI during the study period. Among these patients, 787 (2.1%) experienced severe (Stage 3 or greater) AKI. In multivariable models, the development of severe AKI in the hospital was associated with in-hospital mortality (OR 2.03, 95% CI 1.64-2.52), need for tracheostomy (OR 2.10, 95% CI 1.52-2.89), PEG tube placement (OR 1.88, 95% CI 1.45-2.45), and increased hospital length of stay (p < 0.001). The overall incidence of severe AKI is relatively low (2.1%), but is associated with increased mortality and multiple markers of increased healthcare utilization following severe TBI.

Sections du résumé

BACKGROUND/OBJECTIVE
Traumatic brain injury (TBI) is a leading cause of morbidity, mortality, and disability in the USA. While cardiopulmonary dysfunction can result in poor outcomes following severe TBI, the impact of acute kidney injury (AKI) is poorly understood. We examined the association of severe AKI with hospital mortality and healthcare utilization following isolate severe TBI.
METHODS
We conducted a retrospective cohort study using the National Trauma Data Bank from 2007 to 2014. We identified a cohort of adult patients with isolated severe TBI and described the incidence of severe AKI, corresponding to Acute Kidney Injury Network stage 3 disease or greater. We examined the association of severe AKI with the primary outcome of hospital mortality using multivariable logistic regression models. In secondary analyses, we examined the association of severe AKI with dialysis catheter placement, tracheostomy and gastrostomy utilization, and hospital length of stay.
RESULTS
There were 37,851 patients who experienced isolated severe TBI during the study period. Among these patients, 787 (2.1%) experienced severe (Stage 3 or greater) AKI. In multivariable models, the development of severe AKI in the hospital was associated with in-hospital mortality (OR 2.03, 95% CI 1.64-2.52), need for tracheostomy (OR 2.10, 95% CI 1.52-2.89), PEG tube placement (OR 1.88, 95% CI 1.45-2.45), and increased hospital length of stay (p < 0.001).
CONCLUSIONS
The overall incidence of severe AKI is relatively low (2.1%), but is associated with increased mortality and multiple markers of increased healthcare utilization following severe TBI.

Identifiants

pubmed: 33442812
doi: 10.1007/s12028-020-01183-z
pii: 10.1007/s12028-020-01183-z
pmc: PMC8275693
mid: NIHMS1668763
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

434-440

Subventions

Organisme : NINDS NIH HHS
ID : K23 NS109274
Pays : United States

Informations de copyright

© 2021. Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society.

Références

Rutland-Brown W, Langlois JA, Thomas KE, Xi YL. Incidence of traumatic brain injury in the United States, 2003. J Head Trauma Rehabil. 2006;21:544–8.
doi: 10.1097/00001199-200611000-00009
Saatman KE, Duhaime AC, Bullock R, et al. Classification of traumatic brain injury for targeted therapies. J Neurotrauma. 2008;25:719–38.
doi: 10.1089/neu.2008.0586
Mascia L, Sakr Y, Pasero D, Payen D, Reinhart K, Vincent JL. Extracranial complications in patients with acute brain injury: a post hoc analysis of the SOAP study. Intensive Care Med. 2008;34:720–7.
doi: 10.1007/s00134-007-0974-7
Jeremitsky E, Omert L, Dunham CM, Protetch J, Rodriguez A. Harbingers of poor outcome the day after severe brain injury: hypothermia, hypoxia, and hypoperfusion. J Trauma. 2003;54:312–9.
doi: 10.1097/01.TA.0000037876.37236.D6
Manley G, Knudson MM, Morabito D, Damron S, Erickson V, Pitts L. Hypotension, hypoxia, and head injury: frequency, duration, and consequences. Arch Surg. 2001;136:1118–23.
doi: 10.1001/archsurg.136.10.1118
Krishnamoorthy V, Rowhani-Rahbar A, Gibbons EF, et al. Early systolic dysfunction following traumatic brain injury: a cohort study. Crit Care Med. 2017;45:1028–36.
doi: 10.1097/CCM.0000000000002404
Moore EM, Bellomo R, Nichol A, Harley N, Macisaac C, Cooper DJ. The incidence of acute kidney injury in patients with traumatic brain injury. Ren Fail. 2010;32:1060–5.
doi: 10.3109/0886022X.2010.510234
Maegele M. Coagulopathy after traumatic brain injury: incidence, pathogenesis, and treatment options. Transfusion. 2013;53(Suppl 1):28S–37S.
doi: 10.1111/trf.12033
Corral L, Javierre CF, Ventura JL, Marcos P, Herrero JI, Manez R. Impact of non-neurological complications in severe traumatic brain injury outcome. Crit Care. 2012;16:R44.
doi: 10.1186/cc11243
Lee S, Hwang H, Yamal JM, et al. IMPACT probability of poor outcome and plasma cytokine concentrations are associated with multiple organ dysfunction syndrome following traumatic brain injury. J Neurosurg. 2019;131:1931–7.
doi: 10.3171/2018.8.JNS18676
Lin CY, Chen YC. Acute kidney injury classification: AKIN and RIFLE criteria in critical patients. World J Crit Care Med. 2012;1:40–5.
doi: 10.5492/wjccm.v1.i2.40
Haider AH, Hashmi ZG, Zafar SN, et al. Developing best practices to study trauma outcomes in large databases: an evidence-based approach to determine the best mortality risk adjustment model. J Trauma Acute Care Surg. 2014;76:1061–9.
doi: 10.1097/TA.0000000000000182
Rosner MJ, Newsome HH, Becker DP. Mechanical brain injury: the sympathoadrenal response. J Neurosurg. 1984;61:76–86.
doi: 10.3171/jns.1984.61.1.0076
Koiv L, Merisalu E, Zilmer K, Tomberg T, Kaasik AE. Changes of sympatho-adrenal and hypothalamo-pituitary-adrenocortical system in patients with head injury. Acta Neurol Scand. 1997;96:52–8.
doi: 10.1111/j.1600-0404.1997.tb00238.x
Rizoli SB, Jaja BN, Di Battista AP, et al. Catecholamines as outcome markers in isolated traumatic brain injury: the COMA-TBI study. Crit Care. 2017;21:37.
doi: 10.1186/s13054-017-1620-6
McDonald SJ, Sharkey JM, Sun M, et al. Beyond the brain: peripheral interactions after traumatic brain injury. J Neurotrauma. 2020;37:770–81.
doi: 10.1089/neu.2019.6885
Wiersema R, Eck RJ, Haapio M, et al. Burden of acute kidney injury and 90-day mortality in critically ill patients. BMC Nephrol. 2019;21:1.
doi: 10.1186/s12882-019-1645-y
Ramtinfar S, Chabok SY, Chari AJ, Reihanian Z, Leili EK, Alizadeh A. Early detection of nonneurologic organ failure in patients with severe traumatic brain injury: multiple organ dysfunction score or sequential organ failure assessment? Indian J Crit Care Med. 2016;20:575–80.
doi: 10.4103/0972-5229.192042
Erdman MJ, Riha H, Bode L, Chang JJ, Jones GM. Predictors of Acute kidney injury in neurocritical care patients receiving continuous hypertonic saline. Neurohospitalist. 2017;7:9–14.
doi: 10.1177/1941874416665744
Wilcox CS. Regulation of renal blood flow by plasma chloride. J Clin Invest. 1983;71:726–35.
doi: 10.1172/JCI110820
Maguigan KL, Dennis BM, Hamblin SE, Guillamondegui OD. Method of hypertonic saline administration: effects on osmolality in traumatic brain injury patients. J Clin Neurosci. 2017;39:147–50.
doi: 10.1016/j.jocn.2017.01.025
Zeng J, Tong W, Zheng P. Decreased risk of acute kidney injury with intracranial pressure monitoring in patients with moderate or severe brain injury. J Neurosurg. 2013;119:1228–32.
doi: 10.3171/2013.7.JNS122131
Skrifvars MB, Moore E, Martensson J, et al. Erythropoietin in traumatic brain injury associated acute kidney injury: a randomized controlled trial. Acta Anaesthesiol Scand. 2019;63:200–7.
doi: 10.1111/aas.13244

Auteurs

David Luu (D)

Duke University Medical Center, Department of Anesthesiology, DUMC 3094, Duke University, Durham, NC, 27710, USA.
Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University, Durham, USA.

Jordan Komisarow (J)

Department of Neurosurgery, Duke University, Durham, USA.
Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University, Durham, USA.

Brianna M Mills (BM)

Harborview Injury Prevention and Research Center, University of Washington, Seattle, USA.
Department of Epidemiology, University of Washington, Seattle, USA.

Monica S Vavilala (MS)

Harborview Injury Prevention and Research Center, University of Washington, Seattle, USA.
Departments of Anesthesiology and Pain Medicine, University of Washington, Seattle, USA.

Daniel T Laskowitz (DT)

Departments of Neurology, Duke University, Durham, USA.

Joseph Mathew (J)

Duke University Medical Center, Department of Anesthesiology, DUMC 3094, Duke University, Durham, NC, 27710, USA.

Michael L James (ML)

Duke University Medical Center, Department of Anesthesiology, DUMC 3094, Duke University, Durham, NC, 27710, USA.
Departments of Neurology, Duke University, Durham, USA.
Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University, Durham, USA.

Adrian Hernandez (A)

Departments of Medicine, Duke University, Durham, USA.
Population Health Sciences, Duke University, Durham, USA.

John Sampson (J)

Department of Neurosurgery, Duke University, Durham, USA.

Matt Fuller (M)

Duke University Medical Center, Department of Anesthesiology, DUMC 3094, Duke University, Durham, NC, 27710, USA.
Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University, Durham, USA.

Tetsu Ohnuma (T)

Duke University Medical Center, Department of Anesthesiology, DUMC 3094, Duke University, Durham, NC, 27710, USA.
Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University, Durham, USA.

Karthik Raghunathan (K)

Duke University Medical Center, Department of Anesthesiology, DUMC 3094, Duke University, Durham, NC, 27710, USA.
Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University, Durham, USA.
Population Health Sciences, Duke University, Durham, USA.

Jamie Privratsky (J)

Duke University Medical Center, Department of Anesthesiology, DUMC 3094, Duke University, Durham, NC, 27710, USA.
Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University, Durham, USA.

Raquel Bartz (R)

Duke University Medical Center, Department of Anesthesiology, DUMC 3094, Duke University, Durham, NC, 27710, USA.
Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University, Durham, USA.

Vijay Krishnamoorthy (V)

Duke University Medical Center, Department of Anesthesiology, DUMC 3094, Duke University, Durham, NC, 27710, USA. vijay.krishnamoorthy@duke.edu.
Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University, Durham, USA. vijay.krishnamoorthy@duke.edu.
Population Health Sciences, Duke University, Durham, USA. vijay.krishnamoorthy@duke.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH